Mycophenolate 500 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FWZXM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,646
Award facts
- Contract value 100% obligated
- $1,645.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,645.74 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract is unclassified and has no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The SPE2DX contract enables the company to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Mycophenolate—an immunosuppressive medication commonly used in transplant and autoimmune disease management—exemplifies the company's role in fulfilling ongoing pharmaceutical requirements within the Defense Health Agency supply chain.
Quick answers
Who was awarded contract SPE2DB25FWZXM?
SPE2DB25FWZXM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FWZXM worth?
The government has obligated $1,646 on SPE2DB25FWZXM.
Is contract SPE2DB25FWZXM an order under another contract?
Yes. SPE2DB25FWZXM is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZXM competed?
The extent of competition for SPE2DB25FWZXM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award